Related Experiment Video
Updated: Jul 19, 2026

Streamlined Purification of Plasmid DNA From Prokaryotic Cultures
Published on: January 5, 2011
A place for plasmapheresis
1Department of Immunology, Oslo University Hospital, Oslo, Norway; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
None:
The increased need for source plasma in the production of plasma-derived medical products has received attention and elicited diverse actions in Europe lately. The discrepancy between production and utilization poses ethical as well as medical questions to be discussed in the international community. The contribution of non-remunerated voluntary donors should be encouraged, and several nations have addressed the problem in national plasma strategy documents. Independent of this, blood centers have increased their plasmapheresis activity in efforts to increase plasma donation and retain valuable donors, in parallel with decreased use of cellular blood products. In Oslo Blood Center we have encouraged our whole blood donors to also donate plasma, by which we keep them active and prepared for whole blood donation if an urgent situation rises. In this commentary I describe the change of mind set necessary to increase the number of plasmaphereses within the current frameworks.
Related Concept Videos
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis
Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Hemodialysis I: Introduction
Hemodialysis II: Procedure and Complications

